Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 1:22 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Beryl Capital Management LLC | 0 0% | -6,700,000 (Position Closed) | View |
| 2022-12-08 12:42 pm Unchanged | 13D | APPLIED GENETIC TECHNOLOGIES C AGTC | Tetragon Financial Management LP | 0 0% | 0 (Unchanged) | View |
| 2022-11-04 4:24 pm Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Beryl Capital Management LLC | 6,700,000 9.9% | 6,700,000 (New Position) | View |
| 2022-02-15 2:44 pm Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Portolan Capital Management LLC | 2,218,188 5.17% | 857,484 (+63.02%) | View |
| 2022-02-14 06:17 am Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | INTERWEST PARTNERS VIII LP | 1,414,515 3.3% | 10,000 (+0.71%) | View |
| 2022-02-11 3:32 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Stonepine Capital Management LLC | 0 0% | -2,273,876 (Position Closed) | View |
| 2022-02-11 2:05 pm Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Portolan Capital Management LLC | 1,360,704 3.17% | 52,977 (+4.05%) | View |
| 2022-01-19 11:04 am Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Empery Asset Management LP | 2,244,292 4.99% | -1,688,292 (-42.93%) | View |
| 2021-02-12 4:17 pm Unchanged | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | INTERSOUTH PARTNERS VI LP | 1,214,457 4.7% | 0 (Unchanged) | View |
| 2021-02-12 2:56 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Portolan Capital Management LLC | 1,307,727 5.05% | -1,614 (-0.12%) | View |
| 2021-02-12 2:42 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | DIMENSIONAL FUND ADVISORS LP | 943,381 3.6% | -36,342 (-3.71%) | View |
| 2021-02-12 06:06 am Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | INTERWEST PARTNERS VIII LP | 1,404,515 5.4% | -79,652 (-5.37%) | View |
| 2021-02-10 3:12 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | RENAISSANCE TECHNOLOGIES LLC | 1,016,840 3.93% | -197,500 (-16.26%) | View |
| 2021-02-10 3:04 pm Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | BlackRock Inc. BLK | 1,739,403 4.1% | 7,336 (+0.42%) | View |
| 2021-02-09 5:01 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Stichting Aescap Life Sciences | 17,999 0.1% | -1,787,762 (-99.00%) | View |
| 2021-02-05 6:39 pm Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Stonepine Capital Management LLC | 2,273,876 5.2% | 2,273,876 (New Position) | View |
| 2021-02-02 3:13 pm Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | BlackRock Inc. BLK | 1,732,067 6.7% | 1,269,425 (+274.39%) | View |
| 2021-02-02 10:29 am Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Empery Asset Management LP | 3,932,584 9.23% | 3,932,584 (New Position) | View |
| 2021-01-19 4:21 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | INTEGRATED CORE STRATEGIES (US) LLC | 717,363 2.8% | -794,198 (-52.54%) | View |
| 2020-09-28 1:51 pm Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Portolan Capital Management LLC | 1,309,341 5.06% | 1,309,341 (New Position) | View |